The latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey Welcomes Internationally Recognized Thoracic Surgeon
Aiming to enhance its focus on lung and other cancers of the chest, Rutgers Cancer Institute of New Jersey is welcoming Todd Demmy, MD, FACS, FCCP, as its new Chief of Thoracic Oncology and Associate Chief of the Division of Surgical Oncology. Dr. Demmy, who is also a professor of surgery and Chief, Section of Thoracic Surgery, within the Division of Cardiothoracic Surgery at Rutgers Robert Wood Johnson Medical School, is an international leader in minimally-invasive thoracic surgery and one of the pioneers of video-assisted thoracoscopic surgery (VATS).Learn more
Robert S. DiPaola, MD, Named Vice Chancellor for Cancer Programs
Rutgers Cancer Institute of New Jersey Director Robert DiPaola, MD, was recently named Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences (RBHS). Dr. DiPaola will continue as director of Rutgers Cancer Institute while assuming this new role that will help the university further its progress in the critical area of cancer clinical care and research. He will provide leadership to cancer programs across RBHS to create new connections with particular emphasis on combining strengths to create areas that are nationally "best-in-class." He will be working to increase multi-disciplinary collaborative cancer research including NIH-funded basic science, clinical, translational, and population research and to enhance collaboration with the pharmaceutical industry on research, drug discovery, and clinical trials.
Helping Breast Cancer Patients with a Challenging Decision
Rutgers Cancer Institute of New Jersey surgical oncologist Laurie J. Kirstein, MD, FACS, and Associate Director for Cancer Prevention, Control and Population Science Sharon L. Manne, PhD, both faculty members at Rutgers Robert Wood Johnson Medical School, have been awarded a $400,000 grant from the National Cancer Institute to explore the decision making process women with non-hereditary breast cancer undergo when considering the removal of a healthy breast. The aim is to develop a web-based tool to aid patients in this process.Learn more
Creating New Tools to Guide Personalized Therapy in Advanced Prostate Cancer
Rutgers Cancer Institute of New Jersey researcher Justin Drake, PhD, has been awarded $450,000 in grants to support a pair of three-year projects aimed at developing biomarkers to predict disease progression and guide treatment strategies for advanced prostate cancer using a combination of laboratory cancer models, computational and targeted mass spectrometry approaches. Dr. Drake is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School.Learn more
Rutgers Cancer Institute Physicians Named Among 'Tops' in the Garden State
More than a dozen physicians at Rutgers Cancer Institute of New Jersey have been named as a 'Top Doctor' by Inside Jersey magazine. Based on peer nominations, attributes such as board certification, clinical skills, training, years in practice, achievements and other criteria are reviewed and assessed by a physician-directed research team from Castle Connolly Medical Ltd.Learn more
Kudos to a 'Distinguished Investigator'
Congratulations to Rutgers Cancer Institute Chief Scientific Officer Joseph R. Bertino, MD, who recently received the Distinguished Investigator Award at the Annual Meeting of the American College of Clinical Pharmacology. Dr. Bertino, who is also a University Professor of Medicine and Pharmacology at Rutgers Robert Wood Johnson Medical School, has been internationally recognized for his role in finding curative treatments for leukemia and lymphoma.